CD86 and neoplasm: Intratumoral delivery of rM-FC effectively recruits and activates dendritic cells (DCs), especially CD103+ DCs and CD80+CD86+ DCs, further inducing sufficient migration of effector memory T cells into the tumor microenvironment.